RxDoctor Payments Data

Shannon Cook

Family · Cheyenne, WYNPI 1952384927

Payments from drug & device makers

$372in general payments, 2019–2025

Across 16 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$77
  • Novo Nordisk$55
  • GSK$38
  • AstraZeneca$31
  • Lundbeck LLC$29
  • Novartis$25
  • plus $116 from 6 others

What the payments were for

  • Food & beverage$35696%
  • Education$164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$372 in reported general payments places this provider in the 60th percentile of 284 family providers in Wyoming.

See all family providers in Wyoming

Medicare billing

Part B allowed, 2024
$181,917
Medicare patients
410
Services billed
5,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban155$122,562
Avonex (4 Pack)Interferon Beta-1a11$87,263
TrulicityDulaglutide45$57,821
XareltoRivaroxaban42$44,756
FarxigaDapagliflozin Propanediol42$22,575
OzempicSemaglutide15$19,303
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,934
JardianceEmpagliflozin13$8,834
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$7,942
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$6,110
SynthroidLevothyroxine Sodium111$5,711
Atorvastatin Calcium410$4,693
Pantoprazole Sodium330$4,679
Levothyroxine Sodium706$4,572
SymbicortBudesonide/Formoterol Fumarate11$4,141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$122,562155 claims
Lilly USA, LLCTrulicity$16$57,82145 claims
AstraZenecaFarxiga, Symbicort$31$26,71653 claims
Novo NordiskOzempic$55$19,30315 claims
GSKTrelegy Ellipta$38$9,93415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 284 family providers in Wyoming.

Other family in Cheyenne

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →